Самоконтроль гликемии - неотъемлемый компонент успешного лечения сахарного диабета
- Авторы: Бирюкова Е.В.1, Капустина Л.А.2
-
Учреждения:
- ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И.Евдокимова» Минздрава России
- ГБУЗ «Городская поликлиника №69» Департамента здравоохранения г. Москвы
- Выпуск: Том 19, № 10 (2017)
- Страницы: 132-136
- Раздел: Статьи
- URL: https://bakhtiniada.ru/2075-1753/article/view/94954
- DOI: https://doi.org/10.26442/2075-1753_19.10.132-136
- ID: 94954
Цитировать
Полный текст
Аннотация
Полный текст
Открыть статью на сайте журналаОб авторах
Елена Валерьевна Бирюкова
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И.Евдокимова» Минздрава России
Email: lena@obsudim.ru
д-р мед. наук, проф. каф. эндокринологии и диабетологии 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1
Людмила Анатольевна Капустина
ГБУЗ «Городская поликлиника №69» Департамента здравоохранения г. Москвыканд. мед. наук, зав. отд-нием эндокринологии 111401, Россия, Москва, ул. 2-я Владимирская, д. 31А
Список литературы
- International Diabetes Federation. IDF Diabetes Atlas Seventh Edition http://www.diabete- satlas.org/
- Dedov I.I, Shestakova M.V, Benedetti M.M et al. Prevalence of Type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study). Diabet Res Clin Pract 2016; 115: 90-5.
- Duckworth W.C, McCarren M, Abraira C. Glucose Control and Cardiovascular Complications: The VA Diabetes Tria. Diabetes Care 2001; 24 (5): 942-5.
- Bouche J.L, Hurrell D.J. Cardiovascular Disease and Diabetes. Diabet spectrum 2008; 21 (3): 54-5.
- Orchard T.J, Costacou T, Kretowski A, Nesto R. W Type 1 Diabetes and Coronary Artery Disease. Diabetes Care 2006; 29 (11): 2528-38.
- Bartnik M, Ryden L, Ferrari R et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25 (21): 1880-90.
- Kengne A.P, Patel A, Marre M et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J of Cardiovasc Prevent Rehab 2011; 18: 393-8.
- Khaled A.A, Sekaran M, Ikram S.I. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomed Res 2010; 21 (2): 147-50.
- Milicevic Z, Raz I, Beattie S.D. et al. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 2008; 31 (2): S155-S160.
- Zoungas S, Patel A. Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies. Ann N Y Acad Sci 2010; 1212 (1): 29-40.
- Larsen J, Brekke M, Sandvik L et al. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 2002; 51: 2637-41.
- Massi-Benedetti M. The Cost of Diabetes in Europe - Type II: the CODE-2 Study. Diabe- tolody 2002; 45 (7): S1-4.
- Duckworth W.C, McCarren M, Abraira C. Glucose Control and Cardiovascular Complications: The VA Diabetes Tria. Diabetes Care 2001; 24 (5): 942-5.
- Holman R.R, Paul S.K, Bethel M.A. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-89.
- Аметов A.C., Черникова H.A. Гликемический контроль у пациентов с сахарным диабетом типа 2. Consilium Medicum. 2016; 18 (4): 24-7.
- Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справочник поликлинического врача. 2012; 12: 32-6.
- Blonde L, Karter A.J. Current evidence regarding the value of self monitored blood glucose testing. Am J Med 2005; 118 (Suppl. 9A): 20S-6S.
- Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 2009; 169 (14): 1307-16.
- Рунова Г.Е. Самоконтроль гликемии при сахарном диабете: медицинские и психологические аспекты. Consilium Medicum. 2016; 18 (5): 98-102
- McGeoch G, Derry S, Moore R.A. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev 2007; 23: 423-40.
- Miller K.M, Beck R.W, Bergenstal R.M. et al. Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants. Diabetes Care 2013; 36 (7): 2009-14.29: 2528-38.
- Bosi E, Scavini M, Ceriello A et al. Structured SMBG Improves HbA1 c Through targeted changes in diabetes therapy in patients with non-insulin treated type 2 diabetes: the PRISMA study. Diabetes 2012; 61 (Suppl. 1): A212.
- O’Kane M.J, Bunting B, Copeland M et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174-7.
- Clar C et al. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010; 14 (12).
- Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 13-8.
- ORIGIN Trial Investigators, Gerstein H, Yusuf S et al. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 2008; 155 (1): 26-32.
- Polonsky W.H, Fisher L, Schikman C.H et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care 2011; 34: 262-7.
- Neisser K, Weber C, Wenzel H, Schneider B. Costs of self-measurement of blood glucose (SMBG) regarding morbidity and mortality in type 2 diabetes in a reality of care setting (The ROSSO study No 6). The European Association for the Study of Diabetes. Abstract Volume 42st Annual Meeting, Copenhagen, Malmoe. 2006: p. 141.
- Patton S.R. Adherence to Glycemic Monitoring in Diabetes. J Diabetes Sci Techno 2015; 9 (3): 668-75.
- Hansen M.V, Pedersen-Bjergaard U, Heller S.R et al. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 2009; 85: 183-8.
- Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой. 8-й вып. М., 2017. / Algoritmy spetsializi- rovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I.Dedova, M.V.Shestakovoi. 8-i vyp. M., 2017. [in Russian]
- Snell-Bergeon J.K, Wadwa R.P. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Ther 2012; 14 (Suppl. 1): S51-S58.
- Goto A, Arah O.A, Goto M et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 29 (347): f4533.
- Graveling A.J, Frier B.M. Impaired awareness of hypoglycaemia: a review. Diabetes Metab 2010; 36 (Suppl. 3): S64-74. doi: 10.1016/S1262-3636(10)70470-5
- Schmid C, Haug C, Heinemann L, Freckmann G. System Accuracy of Blood Glucose Monitoring Systems: Impact of Use by Patients and Ambient Conditions. Diabetes Technol Ther 2013; 15 (10): 889-96.
- Kuo C.Y, Hsu C.T, Ho C.S et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther 2011; 13: 596-600.
- Freckmann G, Schmid C, Baumstark A et al. System accuracy evaluation of 43 blood glucose monitoring systems for self- monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol 2012; 6 (5): 1060-75.
- International Standard EN ISO 15197:2013. In Vitro diagnostic test systems: Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Second Edition 2013-05-15. International Organization for Standardization, 2013.
- Dunne N, Viggiani M.T, Pardo S et al. Accuracy Evaluation of CONTOUR®PLUS Compared With Four Blood Glucose Monitoring Systems. Diabetes Ther 2015; 6 (3): 377-88.
- Кочергина И.И. Контроль гликемии у больных сахарным диабетом и кардиальной патологией. Consilium Medicum. 2017; 19 (1): 56-60
Дополнительные файлы
